{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:30:09Z","timestamp":1793021409272,"version":"4.5.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>The microbiota has been observed altered in autoimmune diseases, including idiopathic inflammatory myopathies (IIMs), and associated with different treatments. Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. In this study, 13 patients with active IIMs were enrolled and received 1 \u00d710<jats:sup>6<\/jats:sup> IU of IL-2 subcutaneously every other day for 12 weeks plus standard care. The clinical response and immune response were assessed. Stool samples were obtained to explore the structural and functional alterations of the fecal microbiota targeting the V3\u2013V4 region of the 16S rRNA gene and analyze their associations with clinical and immunological characteristics. Our study demonstrated that diversity of microbiota decreased remarkably in patients with IIMs, compared to healthy controls. The inflammatory-related bacteria, such as <jats:italic>Prevotellaceae<\/jats:italic> increased, while some butyrate-producing bacteria, such as <jats:italic>Pseudobutyrivibrio, Lachnospiraceae, Roseburia<\/jats:italic>, and <jats:italic>Blautia<\/jats:italic>, decreased significantly. The alteration associated with disease activities in patients with IIMs. After low-dose IL-2 treatment, 92.31% (12\/13) of patients achieved IMACS DOI at week 12. Proportion of Treg cells significantly increased at week 12 compared with that in baseline (15.9% [7.73, 19.4%] vs. 9.89% [6.02, 11.8%], <jats:italic>P<\/jats:italic> = 0.015). Interestingly, certain butyrate-producing bacteria increase significantly after IL-2 treatment, like <jats:italic>Lachnospiraceae, Pseudobutyrivibrio, etc.<\/jats:italic>, and are associated with a rise in L-Asparagine and L-Leucine. The effects of low-dose IL-2 on gut microbiota were more apparent in NOD mice. Together, the data presented demonstrated that low-dose IL-2 was effective in active IIMs and highlighted the potential for modifying the intestinal microbiomes of dysbiosis to treat IIMs.<\/jats:p>","DOI":"10.3389\/fcimb.2022.757099","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T08:47:40Z","timestamp":1647247660000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Yunzhi","family":"Zhufeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/annrheumdis-2018-214514","article-title":"Prevotella Copri in Individuals at Risk for Rheumatoid Arthritis","volume":"78","author":"Alpizar-Rodriguez","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.autrev.2005.02.002","article-title":"NOD Mice and Autoimmunity","volume":"4","author":"Aoki","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.immuni.2012.02.012","article-title":"Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation","volume":"36","author":"Ballesteros-Tato","year":"2012","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.canlet.2019.11.019","article-title":"Clostridium Butyricum, a Butyrate-Producing Probiotic, Inhibits Intestinal Tumor Development Through Modulating Wnt Signaling and Gut Microbiota","volume":"469","author":"Chen","year":"2020","journal-title":"Cancer Lett."},{"key":"B5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/cei.13158","article-title":"The Microbiome in Autoimmune Diseases","volume":"195","author":"De Luca","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/srep23561","article-title":"Altered Mucosal Microbiome Diversity and Disease Severity in Sj\u00f6gren Syndrome","volume":"6","author":"de Paiva","year":"2016","journal-title":"Sci. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","article-title":"PICRUSt2 for Prediction of Metagenome Functions","volume":"38","author":"Douglas","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"B8","first-page":"081257","volume-title":"UNOISE2: Improved Error-Correction for Illumina 16S and ITS Amplicon Sequencing. BioRxiv","author":"Edgar","year":"2016"},{"key":"B9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11882-016-0658-x","article-title":"Immunoglobulin Glycosylation Effects in Allergy and Immunity","volume":"16","author":"Epp","year":"2016","journal-title":"Curr. Allergy Asthma Rep."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105912","article-title":"Absolute Reduction of Regulatory T Cells and Regulatory Effect of Short-Term and Low-Dose IL-2 in Polymyositis or Dermatomyositis","volume":"77","author":"Feng","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00157","article-title":"Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis","volume":"11","author":"Gaetani","year":"2020","journal-title":"Front. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1136\/thoraxjnl-2012-202917","article-title":"Microbial Communities in the Respiratory Tract of Patients With Interstitial Lung Disease","volume":"68","author":"Garzoni","year":"2013","journal-title":"Thorax"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1084\/jem.20100209","article-title":"IL-2 Reverses Established Type 1 Diabetes in NOD Mice by a Local Effect on Pancreatic Regulatory T Cells","volume":"207","author":"Grinberg-Bleyer","year":"2010","journal-title":"J. Exp. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e01548","DOI":"10.1128\/mBio.01548-14","article-title":"Intestinal Dysbiosis Associated With Systemic Lupus Erythematosus","volume":"5","author":"Hevia","year":"2014","journal-title":"mBio"},{"key":"B15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and Safety of Low-Dose IL-2 in the Treatment of Systemic Lupus Erythematosus: A Randomised, Double-Blind, Placebo-Controlled Trial","volume":"79","author":"He","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nm.4148","article-title":"Low-Dose Interleukin-2 Treatment Selectively Modulates CD4(+) T Cell Subsets in Patients With Systemic Lupus Erythematosus","volume":"22","author":"He","year":"2016","journal-title":"Nat. Med."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00046","article-title":"Targeting Tregs in Juvenile Idiopathic Arthritis and Juvenile Dermatomyositis-Insights From Other Diseases","volume":"10","author":"Hoeppli","year":"2019","journal-title":"Front. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.1223490","article-title":"Interactions Between the Microbiota and the Immune System","volume":"336","author":"Hooper","year":"2012","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12015","article-title":"Alterations of the Human Gut Microbiome in Multiple Sclerosis","volume":"7","author":"Jangi","year":"2016","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01832","article-title":"Amelioration of Autoimmune Diabetes of NOD Mice by Immunomodulating Probiotics","volume":"11","author":"Kim","year":"2020","journal-title":"Front. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/ijms19030730","article-title":"The Balance of Th17 Versus Treg Cells in Autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nri.2017.7","article-title":"Dysbiosis and the Immune System","volume":"17","author":"Levy","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41591-019-0404-8","article-title":"The Landscape of Cancer Cell Line Metabolism","volume":"25","author":"Li","year":"2019","journal-title":"Nat. Med."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-016-0187-3","article-title":"Role of Intestinal Microbiota and Metabolites on Gut Homeostasis and Human Diseases","volume":"18","author":"Lin","year":"2017","journal-title":"BMC Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1038\/s41467-017-01570-9","article-title":"Regulatory T Cells Control Toxicity in a Humanized Model of IL-2 Therapy","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann. Rheum Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1002\/art.39783","article-title":"Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine","volume":"68","author":"Maeda","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s40744-021-00301-3","article-title":"Treatment of Active Idiopathic Inflammatory Myopathies by Low-Dose Interleukin-2: A Prospective Cohort Pilot Study","volume":"8","author":"Miao","year":"2021","journal-title":"Rheumatol. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrrheum.2018.42","article-title":"Treatment in Myositis","volume":"14","author":"Oddis","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrgastro.2016.165","article-title":"Diet, Microorganisms and Their Metabolites, and Colon Cancer","volume":"13","author":"O\u2019Keefe","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13075-018-1774-x","article-title":"Bradykinin 1 Receptor Blockade Subdues Systemic Autoimmunity, Renal Inflammation, and Blood Pressure in Murine Lupus Nephritis","volume":"21","author":"Qin","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2584","article-title":"VSEARCH: A Versatile Open Source Tool for Metagenomics","volume":"4","author":"Rognes","year":"2016","journal-title":"PeerJ"},{"key":"B34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and Clinical Effects of Low-Dose Interleukin-2 Across 11 Autoimmune Diseases in a Single, Open Clinical Trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-014-0472-1","article-title":"The Role of the Gut Microbiota in the Pathogenesis of Antiphospholipid Syndrome","volume":"17","author":"Ruff","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.immuni.2019.10.001","article-title":"Amino Acids License Kinase Mtorc1 Activity and Treg Cell Function via Small G Proteins Rag and Rheb","volume":"51","author":"Shi","year":"2019","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1590\/s1806-37132011000100015","article-title":"Myositis-Related Interstitial Lung Disease and Antisynthetase Syndrome","volume":"37","author":"Solomon","year":"2011","journal-title":"J. Bras. Pneumol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.gastro.2020.09.014","article-title":"Population-Level Configurations of Gut Mycobiome Across 6 Ethnicities in Urban and Rural China","volume":"160","author":"Sun","year":"2021","journal-title":"Gastroenterology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","article-title":"Mtorc1 Couples Immune Signals and Metabolic Programming to Establish T(reg)-Cell Function","volume":"499","author":"Zeng","year":"2013","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The Oral and Gut Microbiomes Are Perturbed in Rheumatoid Arthritis and Partly Normalized After Treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12916-016-0625-3","article-title":"The Gut Microbiome in Human Immunodeficiency Virus Infection","volume":"14","author":"Zilberman-Schapira","year":"2016","journal-title":"BMC Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrrheum.2011.39","article-title":"Pathogenesis, Classification and Treatment of Inflammatory Myopathies","volume":"7","author":"Zong","year":"2011","journal-title":"Nat. Rev. Rheumatol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.757099\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T08:47:45Z","timestamp":1647247665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.757099\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":42,"alternative-id":["10.3389\/fcimb.2022.757099"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.757099","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"article-number":"757099"}}